home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650320.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
2KB
|
38 lines
Document 0320
DOCN M9650320
TI Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in
Mombasa, Kenya.
DT 9605
AU Jackson DJ; Martin HL Jr; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F;
Mandaliya K; Ndinya-Achola JO; Kreiss JK; Department of Epidemiology,
University of Washington, Seattle; 98104-2499, USA.
SO AIDS. 1995 Nov;9(11):1279-83. Unique Identifier : AIDSLINE MED/96126183
AB OBJECTIVES: To ascertain the level of acceptance of a prophylactic HIV
vaccine trial in high-risk HIV-seronegative heterosexual cohorts of men
and women in Mombasa, Kenya, and to assess the anticipated effects of
participation on risk behavior. METHODS: Standardized questionnaire
administered to a convenience sample of commercial sex workers and
trucking company employees enrolled in prospective cohort studies.
RESULTS: Ninety-six per cent of respondents believed that HIV was a
major problem in Kenya and 86% of men and 94% of women perceived
themselves at risk. One hundred per cent of women and 84% of men
expressed interest in participation in an HIV vaccine trial, after
explanation of the experimental nature of the vaccine, double-blind
placebo-controlled design, prolonged follow-up and potential change in
serostatus. Seventeen per cent of men and 9% of women anticipated an
increase in risk behavior as a result of participation. CONCLUSION: The
majority of individuals in two high-risk cohorts were interested in
participating in Phase III efficacy trials of HIV vaccines. A
significant minority anticipated an increase in risk behavior, which
emphasizes the need for intensive counseling and education throughout a
vaccine trial.
DE Adolescence Adult AIDS Vaccines/*THERAPEUTIC USE Cohort Studies
Double-Blind Method Female Human HIV Infections/*PREVENTION &
CONTROL/PSYCHOLOGY HIV Seronegativity Kenya Male Middle Age
Questionnaires Risk Factors Sex Behavior Support, U.S. Gov't, P.H.S.
CLINICAL TRIAL JOURNAL ARTICLE RANDOMIZED CONTROLLED TRIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).